TETA4 Noninferior to Penicillamine for Stable Wilson's Disease
(MedPage Today) -- Oral maintenance therapy with trientine tetrahydrochloride (TETA4; Cuvrior) was noninferior to penicillamine for patients with stable Wilson's disease, the phase III randomized CHELATE trial showed.
In an intention-to-treat...
Source: MedPage Today Gastroenterology - Category: Gastroenterology Source Type: news
More News: Gastroenterology | Wilson's Disease